The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Cardiac Glycosides as Novel Cancer Therapeutic Agents
Abstract
The class of steroid-like compounds designated cardiac glycosides includes well-known drugs such as digoxin, digitoxin, and ouabain. Their continued efficacy in treatment of congestive heart failure and as anti-arrhythmic agents is well appreciated. Less well known, however, is the emerging role of this category of compounds in the prevention and/or treatment of proliferative diseases such as cancer. New findings within the past five years have revealed these compounds to be involved in complex cell-signal transduction mechanisms, resulting in selective control of human tumor but not normal cellular proliferation. As such, they represent a promising form of targeted cancer chemotherapy. New clinical studies of their anticancer potential as single or adjuvant treatments may provide insight into these potentially valuable therapeutic options. This review focuses on recent findings on cellular pharmacology of cardiac glycosides as they relate to treatment of human cancer and attempts to explain why these agents have been overlooked in the past.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Raghavendra, P. B., Sreenivasan, Y., Ramesh, G. T., & Manna, S. K. (2007) · APOPTOSIS · doi:10.1007/s10495-006-0626-3 · Cited by 50
RetractedRETRACTED ARTICLE: Oleandrin-Mediated Expression of Fas Potentiates Apoptosis in Tumor Cells
Sreenivasan, Y., Raghavendra, P. B., & Manna, S. K. (2006) · Journal of Clinical Immunology · doi:10.1007/s10875-006-9028-0 · Cited by 49
RetractedKaplan, J. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102201.141218 · Cited by 1,181
Schoner, W., & Scheiner-Bobis, G. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00098.2007 · Cited by 456
Na+-K+-ATPase-Mediated Signal Transduction: From Protein Interaction to Cellular Function
Xie, Z. (2003) · Molecular Interventions · doi:10.1124/mi.3.3.157 · Cited by 423
Liu, J., Tian, J., Haas, M., Shapiro, J. I., Askari, A., & Xie, Z. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002950200 · Cited by 391
FXYD proteins: new regulators of Na-K-ATPase
Geering, K. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00126.2005 · Cited by 376
Cardiotonic steroids on the road to anti-cancer therapy
Mijatovic, T., Van Quaquebeke, E., Delest, B., Debeir, O., Darro, F., & Kiss, R. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.06.002 · Cited by 317
McConkey, D. J., Lin, Y., Nutt, L. K., Ozel, H. Z., & Newman, R. A. (2000) · PubMed · Cited by 276
Self-citationROLE OF FXYD PROTEINS IN ION TRANSPORT
Garty, H., & Karlish, S. J. D. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040104.131852 · Cited by 245
Cited by
Autosis and autophagic cell death: the dark side of autophagy
Liu, Y., & Levine, B. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.143 · Cited by 742
Novel therapeutic applications of cardiac glycosides
Prassas, I., & Diamandis, E. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2682 · Cited by 673
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Zhang, H., Qian, D. Z., Tan, Y. S., Lee, K., Gao, P., Ren, Y. R., Rey, S., Hammers, H., Chang, D., Pili, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809763105 · Cited by 624
Liu, Y., Shoji-Kawata, S., Sumpter, R. M., Wei, Y., Ginet, V., Zhang, L., Posner, B., Tran, K. A., Green, D. R., Xavier, R. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319661110 · Cited by 607
Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets
Bagrov, A. Y., Shapiro, J. I., & Fedorova, O. V. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000711 · Cited by 532
Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
Menger, L., Vacchelli, E., Adjemian, S., Martins, I., Ma, Y., Shen, S., Yamazaki, T., Sukkurwala, A. Q., Michaud, M., Mignot, G., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003807 · Cited by 423
Bar, E. E., Lin, A., Mahairaki, V., Matsui, W., & Eberhart, C. G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091021 · Cited by 373
Meng, Z., Yang, P., Shen, Y., Bei, W., Zhang, Y., Ge, Y., Newman, R. A., Cohen, L., Liu, L., Thornton, B., et al. (2009) · Cancer · doi:10.1002/cncr.24602 · Cited by 289
Self-citationCancer as a channelopathy: ion channels and pumps in tumor development and progression
Litan, A., & Langhans, S. A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00086 · Cited by 276
Zhai, J., Dong, X., Yan, F., Guo, H., & Yang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.822726 · Cited by 45
Zhang, H., Xu, W., Omari-Siaw, E., Liu, Y., Chen, B., Chen, D., Yu, J., & Xu, X. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1365393 · Cited by 26
Modulation of endothelial organelle size as an antithrombotic strategy
Ferraro, F., Patella, F., Costa, J. R., Ketteler, R., Kriston‐Vizi, J., & Cutler, D. F. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15084 · Cited by 19
Metadata
- Authors
- Newman, R. A., Yang, P., Pawlus, A. D., & Block, K. I.
- Venue
- Molecular Interventions
- Publisher
- CLOCKSS Archive
- Published
- 2008-02-01
- Volume
- 8
- Issue
- 1
- Pages
- 36-49
- ISSN
- 1534-0384 (ISSN-L)
- OpenAlex
- W2070358111
- Cited by
- 515
- References
- 66
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.